Your browser doesn't support javascript.
loading
Functional neuromuscular impairment in severe intestinal dysmotility.
Gallego, Diana; Malagelada, Carolina; Accarino, Anna; Gori, Alessandra; Malagelada, Juan Ramón; Azpiroz, Fernando; De Giorgio, Roberto; Jimenez, Marcel.
Afiliação
  • Gallego D; Department of Cell Biology, Physiology and Immunology and Neurosciences Institute, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Malagelada C; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Barcelona, Spain.
  • Accarino A; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Barcelona, Spain.
  • Gori A; Digestive System Research Unit, University Hospital Vall d'Hebron, Barcelona, Spain.
  • Malagelada JR; Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Azpiroz F; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Barcelona, Spain.
  • De Giorgio R; Digestive System Research Unit, University Hospital Vall d'Hebron, Barcelona, Spain.
  • Jimenez M; Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain.
Neurogastroenterol Motil ; 30(12): e13458, 2018 12.
Article em En | MEDLINE | ID: mdl-30178519
BACKGROUND: Chronic intestinal pseudo-obstruction (CIPO) and enteric dysmotility (ED) are severe intestinal motility disorders usually associated with underlying neuromuscular abnormalities. OBJECTIVE: To evaluate the in vitro neuromuscular function of patients with severe intestinal motility disorders. METHODS: Full-thickness intestinal biopsies (16 jejunum and 3 ileum) obtained from patients with CIPO (n = 10) and ED (n = 9) were studied using muscle bath and microelectrode techniques. Control samples (n = 6 ileum and n = 6 jejunum) were used to establish the range of normality. KEY RESULTS: Fourteen parameters were defined to assess muscle contractility and nerve-muscle interaction: five to evaluate smooth muscle and interstitial cells of Cajal (ICC) and nine to evaluate inhibitory neuromuscular transmission. For each sample, a parameter was scored 0 if the value was inside the normal range or a value of 1 if it was outside. Patients' samples (CIPO/ED) had more abnormal parameters than controls (P < 0.001 for both jejunum and ileum). Functional abnormalities were found to be heterogeneous. The most prevalent abnormality was a decreased purinergic neuromuscular transmission, which was detected in 43.8% of jejunal samples. CONCLUSIONS AND INFERENCES: Abnormalities of neuromuscular intestinal function are detected in vitro in severe intestinal dysmotility. However, consistent with the heterogeneity of the disease pathophysiology, functional impairment cannot be attributed to a single mechanism. Specifically, defects of purinergic neuromuscular transmission may have an important role in motility disorders of the gastrointestinal tract.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transmissão Sináptica / Motilidade Gastrointestinal / Enteropatias / Músculo Liso / Junção Neuromuscular Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Neurogastroenterol Motil Assunto da revista: GASTROENTEROLOGIA / NEUROLOGIA Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Espanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transmissão Sináptica / Motilidade Gastrointestinal / Enteropatias / Músculo Liso / Junção Neuromuscular Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Neurogastroenterol Motil Assunto da revista: GASTROENTEROLOGIA / NEUROLOGIA Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Espanha